Pregled bibliografske jedinice broj: 951992
Primary Neuroendocrine Carcinoma of the Breast: A Diagnostic Approach to the Special Type of Breast Malignancy
Primary Neuroendocrine Carcinoma of the Breast: A Diagnostic Approach to the Special Type of Breast Malignancy // 14th Annual ENETS conference. Book of abstracts
Barcelona, Španjolska, 2017. str. 305-305 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 951992 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Primary Neuroendocrine Carcinoma of the Breast: A Diagnostic Approach to the Special Type of Breast Malignancy
Autori
Demirović, Alma ; Vranić, Semir ; Skenderi, Faruk ; Perić Balja, Melita ; Ulamec, Monika ; Vučić, Majda ; Krušlin, Božo
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
14th Annual ENETS conference. Book of abstracts
/ - , 2017, 305-305
Skup
Abstracts of the 14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease.
Mjesto i datum
Barcelona, Španjolska, 08.03.2017. - 10.03.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
breast cancer, special types, carcinoma with neuroendocrine features, neuroendocrine markers
Sažetak
Introduction: WHO classification from 2003 defines primary neuroendocrine carcinomas (NEC) of the breast as a group of tumors with expression of neuroendocrine markers in more than 50% of tumor cells. In the current WHO classification this category is renamed to “carcinomas with neuroendocrine features” without defined clear-cut of the percentage of tumor cells positive for neuroendocrine markers. Aim(s): To evaluate diagnostic criteria for primary breast NEC. Materials and methods: Histopathologic reports of patients with breast carcinoma in the last 10 years were analyzed ; cases of breast NEC were selected and reviewed for the positivity for neuroendocrine markers, estrogen receptors (ER), progesterone receptors (PR), HER-2/neu and presence of in situ component. Results: Among 11034 cases of breast carcinoma, 37 primary NEC (incidence rate: 0.3%), and 3 metastatic NEC were identified. Synaptophysin was diffusely positive in 35 (94.6%), chromogranin-A in 32 (86.5%) and NSE in 21 (56.6%). 34 (91.9%) were ER+ ; 32 (86.5%) PR+ ; 3 cases (8.1%) were triple-negative and only one case was HER-2/neu positive. Five out of seven reported cases had ductal carcinoma in situ (CIS) component. Conclusion: Breast NEC is a rare tumor. Positivity for synaptophysin and chromogranin-A is evident in the majority of primary breast NEC. Metastatis must be ruled out to declare it primary. Helpful characteristics for accurate diagnosis are presence of CIS, ER and PR positivity.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore,
KBC "Sestre Milosrdnice"
Profili:
Božo Krušlin
(autor)
Majda Vučić
(autor)
Faruk Skenderi
(autor)
Monika Ulamec
(autor)
Melita Perić Balja
(autor)
Alma Demirović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE